3-MERCAPTO-3-METHYL-BUTYRYL-TYR(ME)-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2

3-MERCAPTO-3-METHYL-BUTYRYL-TYR(ME)-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2

73168-24-8

C₅₂H₇₄ N₁₄ O₁₂ S₂

glycinamide,n-[2-(1-mercaptocyclohexyl)acetyl]-o-methyl-l-tyrosyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-arginyl-,cyclic (1® ; d(ch2)5[tyr(methyl)2,arg8]-vasopressin ; [d(ch2)5,tyr(me)2]arginine vasopressin ; cgp 25838 ; [1-(b-mercapto-b,b-cyclopentamethylenepropionicacid)-2-(o-methyltyrosine)-8-arginine]vasopressin ; skf 100273 ; [d(ch2)5,tyr(me)2]avp ; glycinamide,n-[(1-mercaptocyclohexyl)acetyl]-o-methyl-l-tyrosyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-arginyl-,cyclic (1® ; manning compound ; [pmp1,tyr(me)2]-arg8-vasopressin ; sk&f100273 ; vasopressin,1-(1-mercaptocyclohexaneacetic acid)-2-(o-methyl-l-tyrosine)-8-l-arginine- ; 5)-disulfide ; [pmp1,tyr(ome)2,arg8] vasopressin ; 5)-disulfide (9ci) ; 7,8-dithia-11,14,17,20,23-pentaazaspiro[5.19]pentacosane, cyclic peptidederiv. ; avpa ; aavp ; avpx